 GB Sciences used PhAROSTM, their novel AI-accelerated drug discovery platform, to identify and pre-validate optimized therapeutic mixtures for the treatment of anxiety, depression, and pain from mixtures of compounds identified within Kava and other plants from within the Piper family. LAS VEGAS, NV ACCESSWIRE July 27, 2021 GB Sciences, Inc. OTCQB:GBLX announced the completion of a data science study identifying proprietary therapeutic mixtures from within the Piper plant family. 